Equity Details
Price & Market Data
Price: $0.261
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $4,193,254
Daily Volume: 0
Performance Metrics
1 Week: -6.82%
1 Month: -1.55%
3 Months: -54.23%
6 Months: -69.66%
1 Year: -56.52%
YTD: -62.68%
About AccuStem Sciences, Inc. (ACUT)
Track AccuStem Sciences, Inc. (ACUT)'s latest movements. Priced at 0.261, the stock has a daily change of $0.00 / 0.00%. Its market cap stands at 4,193,254. Gain insights from its 1-year performance (-56.52%) and YTD results.
Company Details
Employees: 4
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-invasive blood testing technologies. AccuStem Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.